New Class of Brain Inhibitory Neurons May Contribute to Autism and Schizophrenia

A University of California, Irvine-led team of researchers working at the Center for Neural Circuit Mapping find links between brain disorders and dysfunction of newly identified inhibitory brain cell types.

The study "Anatomical and molecular characterization of parvalbumin cholecystokinin
co-expressing inhibitory interneurons: implications for neuropsychiatric conditions" was published in July in Molecular Psychiatry.

Different types of brain inhibitory neurons were identified first over one hundred years ago by differences in their shape and form, but their functions are still being uncovered.

A team of UCI scientists led by Xiangmin Xu, PhD, professor of anatomy and neurobiology and director for the Center for Neural Circuit Mapping (CNCM) at the UCI School of Medicine, found that a distinct new class of brain inhibitory neurons when functioning abnormally may contribute to neurological and psychiatric conditions, including autism and schizophrenia.

We've discovered a new class of inhibitory neurons in the brain that are implicated in several neuropsychiatric conditions. These neurons are characterized by their chemical signature of expressing calcium binding protein parvalbumin and the cholecystokinin (CCK) peptide. "

Xiangmin Xu, PhD, Professor and Director, Center for Neural Circuit Mapping, School of Medicine, University of California-Irvine

The nervous system uses a balance of excitatory and inhibitory neurons that interact. Without inhibitory neurons, the brain experiences epilepsy, and other neurological disorders. The class of neurons that Dr. Xu's team discovered are very metabolically active and thus require high levels of energy.

"These key inhibitory neurons effectively act as a braking system of the brain to slow down overall activity," said Xu. "The loss of function of the braking system of the brain leads to abnormal function."

The team is now studying the very active types of neurons with high energy requirements for potential therapies. They are further examining these neurons to better understand their relationship to neuropsychiatric conditions and their contributions to brain function.

Journal reference:

Grieco, S. F., et al. (2023) Anatomical and molecular characterization of parvalbumin-cholecystokinin co-expressing inhibitory interneurons: implications for neuropsychiatric conditions. Molecular Psychiatry.


The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of AZoLifeSciences.
Post a new comment

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Sphere Fluidics Launches Cyto-CellectPLUS to Accelerate Cell Line Development Workflows